F de Marinis Selected Research

F de Marinis Research Topics

13	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2023 - 10/2000
6	Lung Neoplasms (Lung Cancer) 01/2023 - 01/2012
4	Disease Progression 10/2023 - 07/2011
4	Neoplasms (Cancer) 01/2023 - 03/2006
2	Neoplasm Metastasis (Metastasis) 01/2018 - 01/2012
1	COVID-19 01/2023
1	Mesothelioma 01/2023
1	Brain Neoplasms (Brain Tumor) 01/2020
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2020
1	Epilepsy (Aura) 01/2018
1	Fatigue 09/2014
1	Peripheral Nervous System Diseases (PNS Diseases) 10/2000
1	Ototoxicity 10/2000
1	Vomiting 10/2000
1	Arthralgia (Joint Pain) 10/2000
1	Myalgia 10/2000
1	Nausea 10/2000

3	PlatinumIBA 10/2023 - 01/2021
2	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2022
2	osimertinibIBA 10/2022 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 04/2020 - 01/2012
2	Cisplatin (Platino)FDA LinkGeneric 09/2014 - 10/2000
2	Zoledronic Acid (Zometa)FDA Link 08/2012 - 01/2012
1	Aluminum Oxide (Sapphire)IBA 10/2023
1	NivolumabIBA 10/2023
1	cyclopropapyrroloindoleIBA 10/2023
1	Docetaxel (Taxotere)FDA Link 10/2023
1	sitravatinibIBA 10/2023
1	VaccinesIBA 01/2023
1	COVID-19 VaccinesIBA 01/2023
1	mRNA VaccinesIBA 01/2023
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	B7-H1 AntigenIBA 01/2022
1	TEMPOIBA 01/2021
1	Vinorelbine (Navelbine)FDA LinkGeneric 01/2021
1	LigandsIBA 04/2020
1	Tyrosine Kinase InhibitorsIBA 08/2017
1	brigatinibIBA 08/2017
1	Anaplastic Lymphoma KinaseIBA 08/2017
1	Pemetrexed (MTA)FDA Link 09/2014
1	Cetuximab (Erbitux)FDA Link 08/2012
1	Monoclonal AntibodiesIBA 01/2012
1	Diphosphonates (Bisphosphonates)IBA 01/2012
1	RANK LigandIBA 01/2012
1	Denosumab FDA Link 01/2012
1	Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)IBA 01/2012
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 07/2011
1	Sorafenib (BAY 43-9006)FDA Link 07/2011
1	Gemcitabine FDA Link 07/2011
1	Paclitaxel (Taxol)FDA LinkGeneric 10/2000

7	Drug Therapy (Chemotherapy) 10/2023 - 10/2000
5	Therapeutics 10/2023 - 01/2012
4	Immunotherapy 01/2023 - 04/2020
1	Combination Drug Therapy (Combination Chemotherapy) 01/2021
1	Radiotherapy 01/2020
1	Induction Chemotherapy 03/2006
1	TP protocol 10/2000